Il Dong Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 1.76%

Il Dong Pharmaceutical Co Ltd (249420) has an Asset Resilience Ratio of 1.76% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Il Dong Pharmaceutical Co Ltd (249420) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

₩10.11 Billion
≈ $6.85 Million USD Cash + Short-term Investments

Total Assets

₩573.88 Billion
≈ $388.91 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2016–2024)

This chart shows how Il Dong Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Il Dong Pharmaceutical Co Ltd assets under control.

Liquid Assets Composition Over Time

This chart breaks down Il Dong Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Il Dong Pharmaceutical Co Ltd (249420) long-term investment share to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₩0.00 0%
Short-term Investments ₩10.11 Billion 1.76%
Total Liquid Assets ₩10.11 Billion 1.76%

Asset Resilience Insights

  • Limited Liquidity: Il Dong Pharmaceutical Co Ltd maintains only 1.76% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Il Dong Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Il Dong Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Kamada
TA:KMDA
Drug Manufacturers - Specialty & Generic 0.00%
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
Drug Manufacturers - Specialty & Generic 4.94%
Viatris Inc
NASDAQ:VTRS
Drug Manufacturers - Specialty & Generic 1.48%
Takeda Pharmaceutical Company Limited
F:TKDA
Drug Manufacturers - Specialty & Generic 0.69%
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603
Drug Manufacturers - Specialty & Generic 11.60%
Chengdu Kanghong Pharmaceuticals Group Co Ltd
SHE:002773
Drug Manufacturers - Specialty & Generic 4.31%
Yipinhong Pharmaceutical Co Ltd Class A
SHE:300723
Drug Manufacturers - Specialty & Generic 1.01%
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
Drug Manufacturers - Specialty & Generic 5.90%

Annual Asset Resilience Ratio for Il Dong Pharmaceutical Co Ltd (2016–2024)

The table below shows the annual Asset Resilience Ratio data for Il Dong Pharmaceutical Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 2.14% ₩12.61 Billion
≈ $8.54 Million
₩589.04 Billion
≈ $399.19 Million
-2.44pp
2023-12-31 4.58% ₩28.02 Billion
≈ $18.99 Million
₩611.26 Billion
≈ $414.24 Million
+0.53pp
2022-12-31 4.06% ₩26.60 Billion
≈ $18.03 Million
₩655.81 Billion
≈ $444.43 Million
+1.36pp
2021-12-31 2.69% ₩19.09 Billion
≈ $12.94 Million
₩708.97 Billion
≈ $480.46 Million
+2.59pp
2020-12-31 0.10% ₩600.00 Million
≈ $406.61K
₩605.28 Billion
≈ $410.19 Million
-0.08pp
2019-12-31 0.18% ₩1.10 Billion
≈ $748.05K
₩612.72 Billion
≈ $415.23 Million
-0.12pp
2018-12-31 0.30% ₩1.70 Billion
≈ $1.15 Million
₩564.67 Billion
≈ $382.67 Million
+0.23pp
2017-12-31 0.07% ₩376.06 Million
≈ $254.85K
₩564.63 Billion
≈ $382.64 Million
+0.05pp
2016-12-31 0.01% ₩71.17 Million
≈ $48.23K
₩550.35 Billion
≈ $372.97 Million
--
pp = percentage points

About Il Dong Pharmaceutical Co Ltd

KO:249420 Korea Drug Manufacturers - Specialty & Generic
Market Cap
$308.76 Million
₩455.61 Billion KRW
Market Cap Rank
#14784 Global
#471 in Korea
Share Price
₩14460.00
Change (1 day)
+0.28%
52-Week Range
₩12150.00 - ₩44300.00
All Time High
₩75500.00
About

Ildong Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in South Korea. The company offers active lactic acid bacterial and anti-diarrheal agents, antibiotics, antifungal and antiviral products, anti-cancer, antineoplastic agents, and NSAIDs and analgesics, as well as vitamins, minerals, and nutrients; and drugs for blood circulation, cardiovascular and central n… Read more